Additional file 1: of Are there differences among operators in false-negative rates of endosonography with needle aspiration for mediastinal nodal staging of non-small cell lung cancer?

Figure S1. Experience of each operator with EBUS/EUS-NA. Table S1. Baseline characteristics, contents of the procedure, and false negative rate of the total 705 patients analyzed by each operator. Table S2. Baseline characteristics, contents of the procedure, and false negative rate of 681 patients, excluding 24 patients who had false negative result from inaccessible LNs, analyzed by each operator. Table S3. Baseline characteristics, contents of the procedure, and false negative rate of the total 1,737 attempted LNs analyzed by each operator. Table S4. Baseline characteristics, contents of the procedure, and false negative rate of 1,747 attempted LNs (including 10 unattempted accessible LNs) analyzed by each operator. Table S5. Odds ratios for false negative results by operator analyzed by patient with operator A as reference. Table S6. Odds ratios for false negative results by operator analyzed by LN with operator A as reference. (ZIP 91 kb)

补充图S1：每位术者针对支气管内超声（Endobronchial Ultrasound, EBUS）/内镜超声引导下针吸活检（Endoscopic Ultrasound-guided Needle Aspiration, EUS-NA）的操作经验。补充表S1：按术者分层分析的全部705例患者的基线特征、操作流程内容及假阴性率。补充表S2：按术者分层分析的681例患者的基线特征、操作流程内容及假阴性率，该队列剔除了24例因无法穿刺的淋巴结导致假阴性结果的患者。补充表S3：按术者分层分析的全部1737枚拟穿刺淋巴结（Lymph Node, LN）的基线特征、操作流程内容及假阴性率。补充表S4：按术者分层分析的1747枚拟穿刺淋巴结（LN）的基线特征、操作流程内容及假阴性率，该队列包含10枚未尝试穿刺的可及淋巴结。补充表S5：以术者A为参照，按患者分层分析的术者相关假阴性结果比值比。补充表S6：以术者A为参照，按淋巴结（LN）分层分析的术者相关假阴性结果比值比。（压缩包，91 kb）